Variant report
Variant | esv3460934 |
---|---|
Chromosome Location | chr2:179879836-179880589 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs374933890 | chr2:179879837-179879838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs59051988 | chr2:179879843-179879844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs368327336 | chr2:179879846-179879847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs60543279 | chr2:179879849-179879850 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs61222905 | chr2:179879860-179879861 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs56105301 | chr2:179879870-179879871 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs58621012 | chr2:179879877-179879878 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs184215935 | chr2:179879880-179879881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs57529531 | chr2:179879888-179879889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs55792025 | chr2:179879899-179879900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs60792887 | chr2:179879907-179879908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs56371643 | chr2:179879924-179879925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370253992 | chr2:179879936-179879937 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs200261773 | chr2:179879948-179879949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs570070168 | chr2:179879950-179879951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs202150994 | chr2:179879953-179879954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372532079 | chr2:179879954-179879955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs371129270 | chr2:179879957-179879958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs376112999 | chr2:179879958-179879959 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs376915970 | chr2:179879959-179879960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs368647878 | chr2:179879966-179879967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs372392322 | chr2:179879967-179879968 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs375633099 | chr2:179879968-179879969 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs367917719 | chr2:179879970-179879971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551230034 | chr2:179879974-179879975 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs188577352 | chr2:179879975-179879976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571133111 | chr2:179879978-179879979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs200378378 | chr2:179879979-179879980 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs563454258 | chr2:179879981-179879982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs201341925 | chr2:179879985-179879986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs57926916 | chr2:179879991-179879992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375214617 | chr2:179879992-179879993 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs199555096 | chr2:179879993-179879994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs532082547 | chr2:179879995-179879996 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs397938167 | chr2:179879999-179880000 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551891394 | chr2:179880005-179880006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs200664221 | chr2:179880009-179880010 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs191872863 | chr2:179880011-179880012 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs202002653 | chr2:179880012-179880013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs376208411 | chr2:179880013-179880014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs61464252 | chr2:179880025-179880026 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs368051425 | chr2:179880028-179880029 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs142104513 | chr2:179880037-179880038 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs183957511 | chr2:179880065-179880066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs189314222 | chr2:179880081-179880082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs143266834 | chr2:179880085-179880086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs62647556 | chr2:179880087-179880088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs200905397 | chr2:179880100-179880101 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116356743 | chr2:179880103-179880104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs62647557 | chr2:179880106-179880107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Prostate cancer | 18632612 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 18923514 | CNVD |
Schizophrenia | 22241247 | CNVD |
Mental retardation | 21062444 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Schizophrenia | 19348701 | CNVD |
Muscular dystrophy | 17160897 | CNVD |
Cardiomyopathy | 17576883 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:179864000-179885000 | Weak transcription | Primary B cells from cord blood | blood |
2 | chr2:179871000-179882400 | Weak transcription | Thymus | Thymus |
3 | chr2:179879800-179881800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |